Quick Hits: Vaping and Teens, Unapproved Opioid Treatments & More

Quick Hits: Transvaginal Mesh Pulled, New Weight Loss Drug & More

A new report suggests that vaping is a gateway for teens to start tobacco smoking, but may help adults quit tobacco cigarettes. The research team at the National Academies of Sciences, Engineering, and Medicine identified numerous health impacts after analyzing over 800 peer-reviewed scientific studies involving e-cigarette use. The results of the study indicated that teens who vape can experience coughing, wheezing and asthma exacerbations. Additionally, e-cigarettes can explode and cause other serious injuries. Although e-cigarettes have been found to be less harmful than tobacco cigarettes, their short- and long-term effects are currently unknown.Via EurekAlert. Posted January 23, 2018.

The FDA and Federal Trade Commission have issued warning letters to some distributors of opioid cessation treatments for marketing unapproved products with false claims. The companies sell their products online and make claims such as “safe and effective natural supplements.” However, these products have not been demonstrated to be safe and effective and may deter patients from seeking FDA-approved therapies. The firms must respond to the letters within 15 business days. Via FDA. Posted January 24, 2018.

A new review is calling for more clinical trial data to be released on statins because their benefits may be exaggerated. The review, which is published in the British Journal of Sports Medicine, advises doctors to be “inherently skeptical” when prescribing statins to people who do not have a high risk of heart disease. According to the report, results of the cholesterol-lowering drugs may have been manipulated to amplify their benefits and downplay their side effects. The review argues that the data may be tainted due to the fact that the drug companies that developed statins have conducted many of the clinical trials. Via British Journal of Sports Medicine.  Posted January 21, 2018.


Alanna McCatty

Alanna McCatty

Alanna McCatty is founder and CEO of McCatty Scholars, an organization that devises and implements financial literacy programs for students to combat the nationwide issue of the loss of educational opportunity due to the ramifications of burdensome student debt. At MedShadow, she reports on new findings and research on the side effects of prescription drugs. She is a graduate of Pace University.


Did you find this article helpful?


Latest News

FDA Recalls Metformin and NP Thyroid

FDA Recalls Metformin and NP Thyroid

The FDA has issued a recall of two drugs–NP Thyroid and Metformin–after testing revealed that they weren’t up to code. Read more below, and if you’re taking either medication, please be sure to contact your doctor for how to continue treatment responsibly.  NP Thyroid Recalled Thirteen lots of NP Thyroid,…

Can Convalescent Plasma Treat COVID-19 Patients?

Can Convalescent Plasma Treat COVID-19 Patients?

One of the most promising treatments for COVID-19 is convalescent plasma, a component of blood. People who have been infected with the virus and are now healthy have developed COVID-19-fighting antibodies, which, the theory is, can be given to people currently sick with COVID-19 so that those antibodies can boost…

  • Advertisement